Advertisement

Topics

Otsuka buys Visterra for $430mm in cash

15:40 EDT 12 Jul 2018 | Elsevier Business Intelligence

Otsuka Pharmaceutical Co. Ltd. agreed to pay $430mm in cash to acquire Visterra Inc., a privately held company developing ant...

Original Article: Otsuka buys Visterra for $430mm in cash

NEXT ARTICLE

More From BioPortfolio on "Otsuka buys Visterra for $430mm in cash"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...